TSH-receptor antibodies may prevent bone loss in pre- and postmenopausal women with Graves' disease and Graves' orbitopathy

OBJECTIVE: Thyrotoxicosis is established risk factor for osteoporosis due to increased bone turnover. Glucocorticoids often administered for Graves' orbitopathy (GO) have additional negative effect on bone mineral density (BMD). Our aim was to examine the influence of thyroid hormones, TSH, TSH...

Descripción completa

Detalles Bibliográficos
Autores principales: Siderova, Mira, Hristozov, Kiril, Tsukeva, Aleksandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Endocrinologia e Metabologia 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10118993/
https://www.ncbi.nlm.nih.gov/pubmed/29768627
http://dx.doi.org/10.20945/2359-3997000000027

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10118993/
https://www.ncbi.nlm.nih.gov/pubmed/29768627
http://dx.doi.org/10.20945/2359-3997000000027

Ejemplares similares